These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6275640)

  • 1. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective properties of theta-hemolysin obtained by affinity chromatography].
    Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation of a purified theta-hemolysin from C1. perfingens type A and its use for titrating toxins and sera].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):40-3. PubMed ID: 6295033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
    Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
    Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preparation and evaluation of immunogenic properties of Clostridium perfringens type A toxoid].
    Rymkiewicz D; Sawicki J; Brühl A; Sochańska R
    Med Dosw Mikrobiol; 1979; 31(2):95-102. PubMed ID: 228130
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
    Ito A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Properties of C1. perfringens toxoids obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the passive hemagglutination test for the purpose of determining antibody levels following animal immunization with Cl. perfringens toxoid].
    Shemanova GF; Dmitrieva LN; Vlasova EV; Panteleev EI; Moshiashvili IIa
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):85-8. PubMed ID: 193324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitizing properties of purified concentrated Cl. perfringens toxoids].
    Kalinichenko NF; Starobinets ZG; Podgornaia LG; Biriukova SV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):113-5. PubMed ID: 4330843
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effects of clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs.
    Amimoto K; Oishi E; Yasuhar H; Sasak O; Katayama S; Kitajima T; Izumida A; Hirahara T
    J Vet Med Sci; 2001 Aug; 63(8):879-83. PubMed ID: 11558543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of membrane separation methods in the production of Clostridium perfringens toxoid].
    Semenova VD; Nikolaeva AM; Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):32-6. PubMed ID: 9662794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins].
    Nenashev VP; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
    J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The functional activity of wound mononuclear phagocytosing cells in revaccination with a Clostridium perfringens anatoxin].
    Sergeeva TI; Zaĭtseva LG; Chirikova EV; Vasil'eva EI; Babaĭtseva VA; Kornienko OIu
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):63-5. PubMed ID: 7879544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.